Arkolith/Insider Trading/BRVE/Form 4

Forbion Growth Opportunities Fund III Cooperatief U.A.

10% OwnerBraveheart Bio, Inc. (BRVE) · full profile →Form 4 · filed Aug 7, 2026
Net Buying
Open-Market Buys
$64.8M
Open-Market Sells
$0
Net Open-Market Flow
$64.8M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 7, 2026Conversion(C)9.1M—$09.7M
Aug 7, 2026Conversion(C)8.0M—$08.5M
Aug 7, 2026Buy(P)1.9M$18.00$34.6M11.6M
Aug 7, 2026Buy(P)1.7M$18.00$30.2M10.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2026Conversion(C)40.0M—$00
Aug 7, 2026Conversion(C)35.0M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-340528) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Braveheart Bio, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp